Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
We provide 1 form of Acipimox
Acipimox
51037-30-0
|
154.038
|
-0.165
Acipimox is a niacin derivative used as a hypolipidemic agent. Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL. It is used in Fredrickson type IIb and type IV hyperlipoproteinemia.
2-carboxy-5-methylpyrazine-4-oxide | 5-methylpyrazine-2-carboxylic acid-4-oxide | 5-methylpyrazinecarboxylic acid 4-oxide | acipimox
Acipimox is a niacin derivative used as a hypolipidemic agent. Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL. It is used in Fredrickson type IIb and type IV hyperlipoproteinemia.
2-carboxy-5-methylpyrazine-4-oxide | 5-methylpyrazine-2-carboxylic acid-4-oxide | 5-methylpyrazinecarboxylic acid 4-oxide | acipimox
$19/5 mg
(EBC)
1
We provide 0 compound for Acipimox
Powered by Bioz